Clinical Trial Update: A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1) [Phase 1, Phase 2]

View source ↗

Summary

Nkarta, Inc. is conducting a Phase 1/2 study of NKX019 for autoimmune diseases and is currently recruiting. The trial targets lupus nephritis and primary membra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis
• Membranous Nephropathy

Drugs mentioned

• NKX019

Snippet

Sponsor: Nkarta, Inc. | Conditions: Lupus Nephritis, Primary Membranous Nephropathy | Phase 1, Phase 2 | Status: RECRUITING